scholarly journals Erratum to: Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine

2012 ◽  
Vol 19 (6) ◽  
pp. 723-723 ◽  
Author(s):  
Natsuko Kawada ◽  
Hiroyuki Uehara ◽  
Kazuhiro Katayama ◽  
Satoaki Nakamura ◽  
Hidenori Takahashi ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Neoadjuvant Chemoradiation ◽  
Nucleoside Transporter ◽  
Equilibrative Nucleoside Transporter

Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients

2018 ◽  
Vol 102 (4) ◽  
pp. 1052-1062 ◽  
Author(s):  
Remy Klaassen ◽  
Oliver J. Gurney-Champion ◽  
Marc R.W. Engelbrecht ◽  
Jaap Stoker ◽  
Johanna W. Wilmink ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Neoadjuvant Chemoradiation ◽  
Diffusion Weighted Mri ◽  
Diffusion Weighted

Su1644 Human Equilibrate Nucleoside Transporter 1 Expression Predicts Survival of Pancreatic Cancer Patients Trated With Gemcitabine-Based Adjuvant Chemotherapy After Resection

2013 ◽  
Vol 144 (5) ◽  
pp. S-1080
Author(s):  
Toshiyuki Moriya ◽  
Shigemi Fuyama ◽  
Yukinori Kamio ◽  
Koichiro Ozawa ◽  
Shigeo Hasegawa ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Adjuvant Chemotherapy ◽  
Cancer Patients ◽  
Nucleoside Transporter

Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

2009 ◽  
Vol 136 (1) ◽  
pp. 187-195 ◽  
Author(s):  
James J. Farrell ◽  
Hany Elsaleh ◽  
Miguel Garcia ◽  
Raymond Lai ◽  
Ali Ammar ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Nucleoside Transporter ◽  
Equilibrative Nucleoside Transporter
Sign in / Sign up

Export Citation Format

Share Document